Publications by authors named "Linnette Yen"

Claim this Profile
T
The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX ® formulated delayed-release mesalamine.
Aaron Yarlas, Linnette Yen, Paul Hodgkins

Qual Life Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL.
Brennan M R Spiegel, Mark W Reid, Roger Bolus, Cynthia B Whitman, Jennifer Talley, Linnette Yen

Qual Life Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of algorithms to identify acute diverticulitis.
Aniket Kawatkar, Li-Hao Chu, Rajan Iyer, Linnette Yen, Wansu Chen

Pharmacoepidemiol Drug Saf· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute colonic diverticulitis: diagnostic evidence, demographic and clinical features in three practice settings.
Rajan Iyer, George F Longstreth, Li-Hao Chu, Wansu Chen, Linnette Yen

J Gastrointestin Liver Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model.
Jennifer Devlen, Kathleen Beusterien, Linnette Yen, Awais Ahmed, Adam S Cheifetz

Inflamm Bowel Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis.
Jennifer Devlen, Kathleen Beusterien, Linnette Yen, Awais Ahmed, Adam S Cheifetz

J Manag Care Spec Pharm· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis.
Keith Bodger, Linnette Yen, Agota Szende, Gunjan Sharma, Yaozhu J Chen

Eur J Gastroenterol Hepatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk for irritable bowel syndrome after acute diverticulitis.
Erica Cohen, Garth Fuller, Roger Bolus, Rusha Modi, Michelle Vu, Linnette Yen

Clin Gastroenterol Hepatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy.
Kamyar Shahedi, Garth Fuller, Roger Bolus, Erica Cohen, Michelle Vu, Linnette Yen

Clin Gastroenterol Hepatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis.
Linnette Yen, Joanne Wu, Pau L Hodgkins, Russell D Cohen, Michael B Nichol

J Manag Care Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis.
Paul Hodgkins, Linnette Yen, Aaron Yarlas, Robyn Karlstadt, Dory Solomon

Inflamm Bowel Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database.
Jean Lachaine, Linnette Yen, Catherine Beauchemin, Paul Hodgkins

BMC Gastroenterol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis.
Debanjali Mitra, Paul Hodgkins, Linnette Yen, Keith L Davis, Russell D Cohen

BMC Gastroenterol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
Paul Hodgkins, Paul Swinburn, Dory Solomon, Linnette Yen, Sarah Dewilde

Patient· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine.
Anne Prenzler, Linnette Yen, Thomas Mittendorf, J-Matthias von der Schulenburg

BMC Health Serv Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis